Adam Feinberg is the Arthur Hamerschlag Career Development Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University, and is the principal investigator of the Regenerative Biomaterials & Therapeutics Group. He has been in a faculty position since 2010 and has been fortunate to receive funding from notable sources including the NIH Director's New Innovator Award, the NSF CAREER Award, and the Human Frontiers Science Program. This has allowed him to rapidly build a group that has trained over 11 Ph.D. students, 11 M.S. students, and 5 postdoctoral fellows. He has published over 40 peer-reviewed research articles and filed over 15 patent applications.

Feinberg's scientific interests are focused on cell-material interactions and understanding how guidance cues can be encoded in the extracellular space to organize multicellular assembly. His background is in materials science and tissue engineering, providing him with a unique skill set to complete this work. His laboratory is investigating protein-based materials composed of nanostructured extracellular matrix (ECM) proteins for application in a range of applications including muscle tissue engineering, corneal repair, and cancer. To tackle these problems they are using tools of nano- and micro-fabrication in concert with molecular biology and 3-D, live-cell imaging of engineered constructs. His lab has recently developed two novel techniques: (i) an ECM shrink-wrapping technique to build a basement membrane around groups of cells and (ii) a 3-D bioprinting approach that dramatically improves the structures that can be biofabricated using soft ECM gels such as collagen and fibrin.

4N109 Scott Hall
Google Scholar
Adam Feinberg
Regenerative Biomaterials & Therapeutics Group website

Breakthrough: 3D printing the human heart

Tissue Engineering: 3-D Printing of the Heart and Arteries

Tissue Engineering: 3-D Printing of the Heart and Arteries

Adam Feinberg Demonstrates 3-D Bioprinting Process

Leveraging 3-D Printing to Repair Damaged Hearts

Patterning on Topography

Tissue Engineering to Treat Human Disease


2004 Ph.D., Biomedical Engineering, University of Florida

2002 MS, Biomedical Engineering, University of Florida

1999 BS, Materials Science and Engineering, Cornell University

Media mentions


New grant to fund cardiac electrophysiology research

BME/MSE’s Tzahi Cohen-Karni was recently awarded a $3.1 NIH/NHLBI grant to further cardiac electrophysiology research. Over the next five years, Cohen-Karni will partner with Pitt’s Aditi Gurkar (co-PI), BME/MSE’s Adam Feinberg, MechE’s Carmel Majidi, and ECE’s Pulkit Grover to study the role of DNA damage in the cardiac unit using induced pluripotent stem cells.


FluidForm lands investment from Hackensack Meridian Health

CMU spinout company FluidForm, co-founded by BME’s Adam Feinberg, recently announced an investment from Hackensack Meridian Health and its Bear’s Den innovation program, which seeks to drive medical science forward by supporting strategic candidates in biotech and pharma. The investment will enable FluidForm to advance key applications in tissue for drug discovery and surgical repair, including collaboration on preclinical work in 2022.

CMU Engineering

Finding inspiration to rebuild human heart muscle

Using insights from the developing heart, Adam Feinberg and his team are shaping biologically-inspired engineering design principles to rebuild human heart muscle.

CMU Engineering

Tuning synthetic collagen threads for biohybrid robots

Researchers in Victoria Webster-Wood’s Biohybrid and Organic Robotics Group are using techniques from tissue engineering to refine tendon-like collagen threads for a new generation of robots.

CMU Engineering

Dynamic heart model advances engineered heart tissue tech

The Feinberg group’s latest model mimics physiologic loads on engineering heart muscle tissues, yielding an unprecedented view of how genetics and mechanical forces contribute to heart muscle function.

CMU Engineering

Unlocking richer intracellular recordings

A forward-thinking group of researchers from Carnegie Mellon University and Istituto Italiano di Tecnologia has identified a flexible, low-cost, and biocompatible platform for enabling richer intracellular recordings.

American Institute for Medical and Biological Engineering

Engineering faculty named AIMBE Fellows

BME’s Adam Feinberg, ChemE’s Kathryn Whitehead, BME’s Byron Yu, and BME Associate Department Head Conrad Zapanta have been elected to the American Institute for Medical and Biological Engineering’s College of Fellows.

CMU Engineering

The force to shape an organ

Novel biosensor reveals the mechanobiological forces that shape organ development and biological phenomena like hypertension.

CMU Engineering

3D bioprinted heart provides new tool for surgeons

Surgeons will soon have a powerful new tool for planning and practice with the creation of the first full-sized 3D bioprinted model of the human heart.

the Bioengineered Organs Initiative

FluidForm is Fast Co. World Changing Ideas Award finalist

Carnegie Mellon University spinout company FluidForm, co-founded by BME’s Adam Feinberg, was named a finalist for Fast Company’s 2020 World Changing Ideas Award. The company was featured in the experimental category for its Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting technology.

CMU Engineering

Healing large wounds fast

CMU has secured a $22 million DARPA grant to develop a device combining artificial intelligence, bioelectronics, and regenerative medicine to regrow muscle tissue, especially after combat injuries.

BBC Science Focus, Scientific American, WebMD, U.S. News & World Report

Feinberg helps develop technique to 3D print heart segment

BME/MSE’s Adam Feinberg and a team of researchers developed a new bioprinting method that can create parts of the human heart out of collagen, with an accuracy of 0.02 millimeters. The printer pushes collagen into a semisolid gel, the collagen solidifies, and then the gel is washed away.